BOOTHBAY FUND MANAGEMENT, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 90 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$288,000
+678.4%
262,108
+1495.1%
0.02%
+466.7%
Q4 2019$37,000
-68.4%
16,432
-88.1%
0.00%
-72.7%
Q3 2019$117,000
-13.3%
138,0560.0%0.01%
-8.3%
Q2 2019$135,000
-10.6%
138,056
+15.5%
0.01%
-20.0%
Q1 2019$151,000
+190.4%
119,495
+650.2%
0.02%
+87.5%
Q4 2018$52,00015,9290.01%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders